ZAP70
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6ND36 | Y619 | Sugiyama | FAM83G PAWS1 | SSGRGPGPRRPsVAssVsEEyFEVREHSVPLRRRHsEQVAN |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00233 | Y41 | Sugiyama | PSMD9 | SDVQELMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEG |
| O00264 | Y180 | Sugiyama | PGRMC1 HPR6.6 PGRMC | FTFKYHHVGKLLKEGEEPtVysDEEEPKDEsARKND_____ |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O00469 | Y603 | Sugiyama | PLOD2 | MEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLENVWL |
| O00488 | S98 | Sugiyama | ZNF593 ZT86 | THFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRLA |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O14602 | Y35 | Sugiyama | EIF1AY | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEALCFDGV |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15357 | Y1135 | Sugiyama | INPPL1 SHIP2 | SGDDRSCSVLQMAKTLSEVDyAPAGPARSALLPGPLELQPP |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43237 | Y184 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | KIPPEKMRELERKFVKDFQDyMEPEEGCQGsPQRRGPLtsG |
| O43390 | Y296 | Sugiyama | HNRNPR HNRPR | VILYHQPDDKKKNRGFCFLEyEDHKSAAQARRRLMSGKVKV |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43561 | Y156 | SIGNOR|EPSD | LAT | TPVSLPPEPACEDADEDEDDyHNPGyLVVLPDSTPATSTAA |
| O43561 | Y161 | GPS6|SIGNOR|EPSD | LAT | PPEPACEDADEDEDDyHNPGyLVVLPDSTPATSTAAPSAPA |
| O43561 | Y200 | SIGNOR|EPSD | LAT | PALStPGIRDSAFSMESIDDyVNVPEsGEsAEAsLDGSREy |
| O43561 | Y220 | SIGNOR|EPSD | LAT | yVNVPEsGEsAEAsLDGSREyVNVsQELHPGAAKtEPAALs |
| O43561 | Y255 | SIGNOR|EPSD | LAT | EPAALssQEAEEVEEEGAPDyENLQELN_____________ |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y298 | Sugiyama | ACTN4 | ANRICKVLAVNQENEHLMEDyEKLASDLLEWIRRTIPWLED |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y906 | Sugiyama | ACTN4 | yQGPDAVPGALDyKsFStALyGEsDL_______________ |
| O43719 | Y650 | Sugiyama | HTATSF1 | EEDtyEKVFDDEsDEKEDEEyADEKGLEAADKKAEEGDADE |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60341 | S137 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | KVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPPPQ |
| O60341 | Y135 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | RAKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPP |
| O60341 | Y136 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | AKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPPP |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y293 | Sugiyama | SYNCRIP HNRPQ NSAP1 | VILyHQPDDKKKNRGFCFLEyEDHKTAAQARRRLMSGKVKV |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60610 | Y374 | Sugiyama | DIAPH1 DIAP1 | ENEDMRVQLNVFDEQGEEDsyDLKGRLDDIRMEMDDFNEVF |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60828 | Y209 | Sugiyama | PQBP1 NPW38 JM26 | KSKKAVSRKDEELDPMDPSsysDAPRGTWstGLPKRNEAKT |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | Y134 | Sugiyama | EIF5B IF2 KIAA0741 | EELEDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKA |
| O60869 | Y109 | Sugiyama | EDF1 | GLtQKDLATKINEKPQVIADyESGRAIPNNQVLGKIERAIG |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75190 | Y4 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | _________________MVDyyEVLGVQRHAsPEDIKKAYR |
| O75190 | Y5 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | ________________MVDyyEVLGVQRHAsPEDIKKAYRK |
| O75190 | Y53 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | DKNPENKEEAERKFKQVAEAyEVLSDAKKRDIYDKYGKEGL |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75822 | Y254 | Sugiyama | EIF3J EIF3S1 PRO0391 | ATMKDDLADyGGyDGGyVQDyEDFM________________ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O94992 | S268 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EDGGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELI |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95340 | Y182 | Sugiyama | PAPSS2 ATPSK2 | GLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVSDC |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O96019 | Y68 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPL |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02730 | Y8 | GPS6 | SLC4A1 AE1 DI EPB3 | _____________MEELQDDyEDMMEENLEQEEyEDPDIPE |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04083 | Y21 | Sugiyama | ANXA1 ANX1 LPC1 | MAMVsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPt |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04920 | Y73 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | EAGsRGGEEPGRsYGEEDFEyHRQSSHHIHHPLSTHLPPDA |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | S280 | Sugiyama | KRT8 CYK8 | IAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y286 | Sugiyama | KRT8 CYK8 | QyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTE |
| P05997 | Y1311 | Sugiyama | COL5A2 | HPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYCNME |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y257 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | TDKVVIGMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLA |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | T101 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAGRE |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y526 | Sugiyama | HEXB HCC7 | ASAVGERLWSSKDVRDMDDAyDRLTRHRCRMVERGIAAQPL |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y438 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KKCLELFtELAEDKENyKKFyEQFSKNIKLGIHEDsQNRKK |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07954 | Y110 | Sugiyama | FH | tPVIKAFGILKRAAAEVNQDyGLDPKIANAIMKAADEVAEG |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09001 | Y265 | Sugiyama | MRPL3 MRL3 RPML3 | TGDIGRVWPGTKMPGKMGNIyRTEYGLKVWRINTKHNIIYV |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | T14 | Sugiyama | SNRPC | _______MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENV |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09496 | Y147 | Sugiyama | CLTA | NSRKQEAEWKEKAIKELEEWyARQDEQLQKTKANNRVADEA |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09874 | Y794 | Sugiyama | PARP1 ADPRT PPOL | AySLLRGGsDDssKDPIDVNyEKLKTDIKVVDRDSEEAEII |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P10636 | Y29 | PSP | MAPT MAPTL MTBT1 TAU | EVMEDHAGTyGLGDRKDQGGytMHQDQEGDtDAGLKEsPLQ |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11274 | Y246 | Sugiyama | BCR BCR1 D22S11 | ASRPPYRGRssEssCGVDGDyEDAELNPRFLKDNLIDANGG |
| P11413 | Y322 | Sugiyama | G6PD | NVVLGQYVGNPDGEGEATKGyLDDPTVPRGSTTATFAAVVL |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14618 | Y148 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14927 | Y90 | Sugiyama | UQCRB UQBP | NLKHQILPKEQWTKyEEENFyLEPyLKEVIRERKEREEWAK |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15374 | Y141 | Sugiyama | UCHL3 | KFLEEsVsMsPEERARyLENyDAIRVtHEtsAHEGQTEAPs |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P15941 | Y1203 | SIGNOR | MUC1 PUM | VCQCRRKNYGQLDIFPARDTyHPMsEyPtyHtHGRyVPPss |
| P15941 | Y1229 | EPSD | MUC1 PUM | yPtyHtHGRyVPPsstDRsPyEKVsAGNGGssLsytNPAVA |
| P16410 | Y201 | GPS6 | CTLA4 CD152 | LTAVSLSKMLKKRSPLTTGVyVKMPPTEPECEKQFQPyFIP |
| P16410 | Y218 | GPS6 | CTLA4 CD152 | TGVyVKMPPTEPECEKQFQPyFIPIN_______________ |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18583 | Y1790 | Sugiyama | SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 | PVVssMPERAsEsssEEKDDyEIFVKVKDTHEKSKKNKNRD |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19387 | Y142 | Sugiyama | POLR2C A-152E5.7 | SNsPRVIPVTSRNRDNDPNDyVEQDDILIVKLRKGQELRLR |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21333 | Y2305 | Sugiyama | FLNA FLN FLN1 | FEDRKDGsCGVAyVVQEPGDyEVsVKFNEEHIPDsPFVVPV |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22059 | Y456 | Sugiyama | OSBP OSBP1 | MPVNFNEPLSMLQRLTEDLEyHELLDRAAKCENSLEQLCYV |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | S56 | Sugiyama | UBA1 A1S9T UBE1 | VPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVL |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23246 | S491 | Sugiyama | SFPQ PSF | QKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEKN |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23381 | Y212 | Sugiyama | WARS1 IFI53 WARS WRS | VIQMTDDEKYLWKDLtLDQAysyAVENAKDIIACGFDINKT |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P23921 | Y556 | Sugiyama | RRM1 RR1 | yyGALEASCDLAKEQGPyEtyEGsPVsKGILQYDMWNVTPT |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y256 | Sugiyama | ACAT1 ACAT MAT | IPVtVtVKGQPDVVVKEDEEyKRVDFSKVPKLKTVFQKENG |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y705 | Sugiyama | MCM3 | QEQKRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKT |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26639 | T574 | Sugiyama | TARS1 TARS | RYHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAIL |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27708 | Y602 | Sugiyama | CAD | FAHTSQVLVDKSLKGWKEIEyEVVRDAYGNCVTVCNMENLD |
| P27797 | Y57 | Sugiyama | CALR CRTC | WIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDARFyAL |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P29353 | Y349 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SHC1 SHC SHCA | MAGFDGSAWDEEEEEPPDHQyyNDFPGKEPPLGGVVDMRLR |
| P29353 | Y350 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SHC1 SHC SHCA | AGFDGSAWDEEEEEPPDHQyyNDFPGKEPPLGGVVDMRLRE |
| P29353 | Y427 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y479 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | NKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1031 | Sugiyama | CPS1 | VVVNCNPETVstDFDECDKLyFEELSLERILDIYHQEACGG |
| P31327 | Y634 | Sugiyama | CPS1 | FAMTNQILVEKSVTGWKEIEyEVVRDADDNCVTVCNMENVD |
| P31689 | Y52 | Sugiyama | DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4 | KYHPDKNPNEGEKFKQISQAyEVLSDAKKRELYDKGGEQAI |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32929 | Y60 | Sugiyama | CTH | PISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDG |
| P32969 | S182 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | QQATTVKNKDIRKFLDGIyVsEKGtVQQADE__________ |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P34932 | Y660 | Sugiyama | HSPA4 APG2 HSPH2 | VSEDDRNsFtLKLEDTENWLyEDGEDQPKQVYVDKLAELKN |
| P35606 | Y794 | Sugiyama | COPB2 | RENLSKVNQKAAEsLADPtEyENLFPGLKEAFVVEEWVKET |
| P36871 | T426 | Sugiyama | PGM1 | KQsVEDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLE |
| P36871 | Y430 | Sugiyama | PGM1 | EDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLEALMF |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38919 | Y54 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VDVTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIK |
| P38919 | Y56 | Sugiyama | EIF4A3 DDX48 KIAA0111 | VTPTFDTMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIKGR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40429 | Y192 | Sugiyama | RPL13A | KQLMRLRKQAEKNVEKKIDKyTEVLKTHGLLV_________ |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y773 | Sugiyama | MATR3 KIAA0723 | DPNKDtsENADGQsDENKDDyTIPDEYRIGPYQPNVPVGID |
| P43403 | S260 | Sugiyama | ZAP70 SRK | KLKADGLIyCLKEACPNSSAsNAsGAAAPTLPAHPSTLTHP |
| P43403 | S263 | Sugiyama | ZAP70 SRK | ADGLIyCLKEACPNSSAsNAsGAAAPTLPAHPSTLTHPQRR |
| P43403 | S289 | Sugiyama | ZAP70 SRK | TLPAHPSTLTHPQRRIDtLNsDGytPEPARItsPDKPRPMP |
| P43403 | S491 | Sugiyama | ZAP70 SRK | NRHyAKISDFGLSKALGADDsyytARSAGKWPLKWyAPECI |
| P43403 | T207 | Sugiyama | ZAP70 SRK | FLLRPRKEQGTyALSLIyGKtVyHyLISQDKAGKYCIPEGT |
| P43403 | T286 | Sugiyama | ZAP70 SRK | AAPTLPAHPSTLTHPQRRIDtLNsDGytPEPARItsPDKPR |
| P43403 | T293 | Sugiyama | ZAP70 SRK | HPSTLTHPQRRIDtLNsDGytPEPARItsPDKPRPMPMDts |
| P43403 | Y12 | EPSD | ZAP70 SRK | _________MPDPAAHLPFFyGSIsRAEAEEHLKLAGMADG |
| P43403 | Y126 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ZAP70 SRK | sGLEPQPGVFDCLRDAMVRDyVRQTWKLEGEALEQAIISQA |
| P43403 | Y198 | Sugiyama | ZAP70 SRK | ySGAQTDGKFLLRPRKEQGTyALSLIyGKtVyHyLISQDKA |
| P43403 | Y204 | Sugiyama | ZAP70 SRK | DGKFLLRPRKEQGTyALSLIyGKtVyHyLISQDKAGKYCIP |
| P43403 | Y209 | Sugiyama | ZAP70 SRK | LRPRKEQGTyALSLIyGKtVyHyLISQDKAGKYCIPEGTKF |
| P43403 | Y211 | Sugiyama | ZAP70 SRK | PRKEQGTyALSLIyGKtVyHyLISQDKAGKYCIPEGTKFDT |
| P43403 | Y248 | Sugiyama | ZAP70 SRK | KFDTLWQLVEYLKLKADGLIyCLKEACPNSSAsNAsGAAAP |
| P43403 | Y292 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | ZAP70 SRK | AHPSTLTHPQRRIDtLNsDGytPEPARItsPDKPRPMPMDt |
| P43403 | Y315 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ZAP70 SRK | EPARItsPDKPRPMPMDtsVyEsPysDPEELKDKKLFLKRD |
| P43403 | Y319 | SIGNOR|iPTMNet|EPSD|PSP | ZAP70 SRK | ItsPDKPRPMPMDtsVyEsPysDPEELKDKKLFLKRDNLLI |
| P43403 | Y397 | Sugiyama | ZAP70 SRK | KADTEEMMREAQIMHQLDNPyIVRLIGVCQAEALMLVMEMA |
| P43403 | Y492 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | ZAP70 SRK | RHyAKISDFGLSKALGADDsyytARSAGKWPLKWyAPECIN |
| P43403 | Y493 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | ZAP70 SRK | HyAKISDFGLSKALGADDsyytARSAGKWPLKWyAPECINF |
| P43403 | Y597 | PSP | ZAP70 SRK | IYKWEDRPDFLTVEQRMRACyysLASKVEGPPGSTQKAEAA |
| P43403 | Y598 | PSP | ZAP70 SRK | YKWEDRPDFLTVEQRMRACyysLASKVEGPPGSTQKAEAAC |
| P43403 | Y69 | Sugiyama | ZAP70 SRK | SLVHDVRFHHFPIERQLNGTyAIAGGKAHCGPAELCEFysR |
| P43403 | Y87 | Sugiyama | ZAP70 SRK | GTyAIAGGKAHCGPAELCEFysRDPDGLPCNLRKPCNRPsG |
| P43490 | Y471 | Sugiyama | NAMPT PBEF PBEF1 | EEYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH |
| P45973 | Y20 | Sugiyama | CBX5 HP1A | _MGKKTKRtADssssEDEEEyVVEKVLDRRVVKGQVEYLLK |
| P46063 | Y61 | Sugiyama | RECQL RECQ1 RECQL1 | VLTKKIKQCLEDsDAGAsNEyDssPAAWNKEDFPWSGKVKD |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47712 | Y456 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | DsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVSDS |
| P47712 | Y535 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | sFDDDELDAAVADPDEFERIyEPLDVKSKKIHVVDSGLTFN |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47813 | Y35 | Sugiyama | EIF1AX EIF1A EIF4C | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEAMCFDGV |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P49588 | Y690 | Sugiyama | AARS1 AARS | DCPLAAAKAIQGLRAVFDEtyPDPVRVVSIGVPVSELLDDP |
| P49736 | Y137 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MRQRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERA |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P50395 | Y197 | Sugiyama | GDI2 RABGDIB | LGQDVIDFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLA |
| P50402 | Y94 | Sugiyama | EMD EDMD STA | yDLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPS |
| P50402 | Y95 | Sugiyama | EMD EDMD STA | DLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPSR |
| P50502 | Y213 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | RLLGHWEEAAHDLALACKLDyDEDAsAMLKEVQPRAQKIAE |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51452 | Y138 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DUSP3 VHR | GRVLVHCREGYSRSPTLVIAyLMMRQKMDVKSALSIVRQNR |
| P51452 | Y38 | EPSD|PSP | DUSP3 VHR | DGSGCYsLPSQPCNEVTPRIyVGNAsVAQDIPKLQKLGITH |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52655 | Y365 | Sugiyama | GTF2A1 TF2A1 | SKNKWKFHLKDGIMNLNGRDyIFSKAIGDAEW_________ |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52948 | Y627 | Sugiyama | NUP98 ADAR2 | NsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDENHQQ |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | T290 | Sugiyama | YARS1 YARS | PLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLK |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55081 | Y276 | Sugiyama | MFAP1 | KRsLAALDALNtDDENDEEEyEAWKVRELKRIKRDREDREA |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y48 | Sugiyama | EIF4A1 DDX2A EIF4A | NEIVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIK |
| P60842 | Y50 | Sugiyama | EIF4A1 DDX2A EIF4A | IVDSFDDMNLSESLLRGIyAyGFEKPsAIQQRAILPCIKGy |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y242 | Sugiyama | ACTR1A CTRN1 | CYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELL |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62195 | Y148 | Sugiyama | PSMC5 SUG1 | PNKVDPLVSLMMVEKVPDSTyEMIGGLDKQIKEIKEVIELP |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y20 | Sugiyama | YWHAE | _MDDREDLVyQAKLAEQAERyDEMVESMKKVAGMDVELTVE |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62847 | Y81 | Sugiyama | RPS24 | RTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYEKKK |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P80303 | Y350 | Sugiyama | NUCB2 NEFA | PDsWEtLDQQQFFtEEELKEyENIIALQENELKKKADELQK |
| P80303 | Y389 | Sugiyama | NUCB2 NEFA | QKQKEELQRQHDQLEAQKLEyHQVIQQMEQKKLQQGIPPSG |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00534 | Y13 | Sugiyama | CDK6 CDKN6 | ________MEKDGLCRADQQyECVAEIGEGAyGKVFKARDL |
| Q00610 | Y1487 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEF |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01082 | T779 | Sugiyama | SPTBN1 SPTB2 | WMLDILKIVssSDVGHDEystQsLVKKHKDVAEEIANYRPT |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01814 | Y1152 | Sugiyama | ATP2B2 PMCA2 | RGLNRIQtQIRVVKAFRssLyEGLEKPEsRtsIHNFMAHPE |
| Q01844 | Y417 | Sugiyama | EWSR1 EWS | MIHIYLDKETGKPKGDATVSyEDPPtAKAAVEWFDGKDFQG |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04637 | Y594 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | WDSKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDR |
| Q04637 | Y596 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | SKEDKIHNAENIQPGEQKyEyKsDQWKPLNLEEKKRYDREF |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05519 | T422 | Sugiyama | SRSF11 SFRS11 | KDKEKDRERKSEsDKDVKQVtRDyDEEEQGYDsEKEKKEEK |
| Q05519 | Y425 | Sugiyama | SRSF11 SFRS11 | EKDRERKSEsDKDVKQVtRDyDEEEQGYDsEKEKKEEKKPI |
| Q05682 | Y160 | Sugiyama | CALD1 CAD CDM | DTAENETTEKEEKsESRQERyEIEETEtVtKSYQKNDWRDA |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07960 | Y64 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | sDDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRK |
| Q07960 | Y65 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | DDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRKI |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12874 | Y479 | Sugiyama | SF3A3 SAP61 | WAKLKLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQG |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13094 | Y113 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LCP2 | EETESHEEDNGGWSSFEEDDyESPNDDQDGEDDGDyEsPNE |
| Q13094 | Y128 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LCP2 | FEEDDyESPNDDQDGEDDGDyEsPNEEEEAPVEDDADyEPP |
| Q13094 | Y145 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | LCP2 | DGDyEsPNEEEEAPVEDDADyEPPPSNDEEALQNSILPAKP |
| Q13094 | Y423 | SIGNOR | LCP2 | PNKPRPPsPAEEENsLNEEWyVSyITRPEAEAALRKINQDG |
| Q13094 | Y426 | SIGNOR | LCP2 | PRPPsPAEEENsLNEEWyVSyITRPEAEAALRKINQDGTFL |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y371 | Sugiyama | SF3B2 SAP145 | EKDSTRsRGsDsPAADVEIEyVtEEPEIyEPNFIFFKRIFE |
| Q13435 | Y379 | Sugiyama | SF3B2 SAP145 | GsDsPAADVEIEyVtEEPEIyEPNFIFFKRIFEAFKLTDDV |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13561 | Y313 | Sugiyama | DCTN2 DCTN50 | IAKHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRL |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13573 | Y459 | Sugiyama | SNW1 SKIIP SKIP | GGKDMAQsIyRPSKNLDKDMyGDDLEARIKTNRFVPDKEFS |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | T863 | Sugiyama | UBAP2L KIAA0144 NICE4 | ttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTLAQPQ |
| Q14240 | Y49 | Sugiyama | EIF4A2 DDX2B EIF4F | NEIVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIK |
| Q14240 | Y51 | Sugiyama | EIF4A2 DDX2B EIF4F | IVDNFDDMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIKGy |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14257 | Y122 | Sugiyama | RCN2 ERC55 | AKQQFVEYDKNSDDTVTWDEyNIQMyDRVIDFDENtALDDA |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14320 | Y53 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | QRIAEENIMKSNIDKKFsAHyDAVEAELKsstVGLVtLNDM |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y114 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | SERVVTSAREHIyDLRSLENyHFVDEHGKDQGINIRQKVKE |
| Q14697 | Y489 | Sugiyama | GANAB G2AN KIAA0088 | PHIKVDSGyRVHEELRNLGLyVKtRDGSDyEGWCWPGSAGY |
| Q14764 | Y389 | Sugiyama | MVP LRP | AKVEVVEERQAIPLDENEGIyVQDVKTGKVRAVIGSTYMLT |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y228 | Sugiyama | RCN1 RCN | VLEtLEDIDKNGDGFVDQDEyIADMFSHEENGPEPDWVLSE |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15631 | Y210 | Sugiyama | TSN | sLRKRYDGLKYDVKKVEEVVyDLSIRGFNKETAAACVEK__ |
| Q15654 | Y123 | Sugiyama | TRIP6 OIP1 | tLAELNGGRGHASRRPDRQAyEPPPPPAyRtGsLKPNPAsP |
| Q16539 | Y323 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | LAHAYFAQYHDPDDEPVADPyDQsFESRDLLIDEWKSLTYD |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q2NKX8 | T1202 | Sugiyama | ERCC6L PICH | GEQLVGsPQDKAAEATNDyEtLVKRGKELKECGKIQEALNC |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5SW79 | Y532 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | EEVEARKMIDKVFGVDDNQDyNRPVINEKHKDLIKDWALss |
| Q5U5X0 | Y96 | Sugiyama | LYRM7 C5orf31 MZM1L | TDHNTLKLVPRKDLLVENVPyCDAPTQKQ____________ |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6QNY0 | Y40 | Sugiyama | BLOC1S3 BLOS3 | GEAtEtDsERsAsssEEEELyLGPSGPTRGRPTGLRVAGEA |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7Z3K3 | Y33 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | EELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPV |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8IVD9 | Y196 | Sugiyama | NUDCD3 KIAA1068 | QKNPDSYNGAVRENYTWsQDyTDLEVRVPVPKHVVKGKQVS |
| Q8IWX8 | Y894 | Sugiyama | CHERP DAN26 SCAF6 | GDVRDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDE |
| Q8IWX8 | Y897 | Sugiyama | CHERP DAN26 SCAF6 | RDKWDQYKGVGVALDDPyENyRRNKsysFIARMKARDECK_ |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1K5 | Y174 | PSP | THEMIS C6orf190 C6orf207 | VARNHQTHSFNLPLSQEGEFyECEDERIYTLKEIVEWKIPK |
| Q8N1K5 | Y353 | PSP | THEMIS C6orf190 C6orf207 | LIPTSYKGKFKRRPREFPTAyDLEIAKSEKEPLHVVATKAF |
| Q8N1K5 | Y429 | PSP | THEMIS C6orf190 C6orf207 | NVLACEKILKKSYEAALLPLyMEGGFVEVIHDKKQYPISEL |
| Q8N1K5 | Y540 | EPSD|PSP | THEMIS C6orf190 C6orf207 | SRDAEPFLVRTLVEEITEEQyyMMRRYESSASHPPPRPPKH |
| Q8N1K5 | Y541 | EPSD|PSP | THEMIS C6orf190 C6orf207 | RDAEPFLVRTLVEEITEEQyyMMRRYESSASHPPPRPPKHP |
| Q8N1K5 | Y95 | PSP | THEMIS C6orf190 C6orf207 | PFELPMNFPGLFKIVADKTPyLTMEEITRTIHIGPSRLGHP |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NFI4 | Y213 | Sugiyama | ST13P5 FAM10A5 | RLLGHWEEAAHDLAFACKLDyDEDAsAMLKEVQPRAQKIAE |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TEW0 | S386 | Sugiyama | PARD3 PAR3 PAR3A | YEQLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAP |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WWF6 | Y53 | Sugiyama | DNAJB3 HCG3 | DKNPENKEEAERRFKQVAEAyEVLSDAKKRDIYDRYGEAGA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q8WWM7 | Y277 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | FKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRAA |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92598 | Y677 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | ICEQDHQNFLRLLTETEDWLyEEGEDQAKQAyVDKLEELMK |
| Q92785 | Y172 | Sugiyama | DPF2 BAF45D REQ UBID4 | RARKRILEPDDFLDDLDDEDyEEDtPKRRGKGKSKGKGVGS |
| Q92796 | Y673 | Sugiyama | DLG3 KIAA1232 | GSCVPHTTRPRRDNEVDGQDyHFVVsREQMEKDIQDNKFIE |
| Q92905 | Y203 | Sugiyama | COPS5 CSN5 JAB1 | LGAFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQYYA |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96A49 | Y327 | Sugiyama | SYAP1 PRO3113 | AVLEEDsADWEKELQQELQEyEVVtESEKRDENWDKEIEKM |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96CW6 | Y300 | Sugiyama | SLC7A6OS | GSSRQRMWSKYPLDVQKEFGyDsPHDLDsD___________ |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96GA3 | Y66 | Sugiyama | LTV1 C6orf93 | IDNEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSST |
| Q96GA3 | Y68 | Sugiyama | LTV1 C6orf93 | NEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSSTFS |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96I25 | Y194 | Sugiyama | RBM17 SPF45 | AIAPPTSLVEKDKELPRDFPyEEDSRPRsQsSKAAIPPPVy |
| Q96I25 | Y214 | Sugiyama | RBM17 SPF45 | yEEDSRPRsQsSKAAIPPPVyEEQDRPRsPtGPsNsFLANM |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q99459 | T510 | Sugiyama | CDC5L KIAA0432 PCDC5RP | FEIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAER |
| Q99459 | Y511 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAERV |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y544 | Sugiyama | ACO2 | LEAPDADELPKGEFDPGQDtyQHPPKDSsGQHVDVsPtsQR |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BS26 | Y175 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | tLDRSKRNIIGYFEQKDSDNyRVFERVANILHDDCAFLSAF |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BVA0 | Y382 | Sugiyama | KATNB1 | SSEDDRDERESRAEIQNAEDyNEIFQPKNSISRtPPRRsEP |
| Q9BY32 | Y45 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | QILGDKFPCTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9C0C2 | Y1122 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | FsPGQQDWsRDFCIEASERsyQFGIIGNDRVsGAGFsPssK |
| Q9C0C2 | Y897 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ssRDVsLGDWEFGKRDsLGAyAsQDANEQGQDLGKRDHHGR |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H7Z7 | Y308 | Sugiyama | PTGES2 C9orf15 PGES2 | LISKRLKSRHRLQDNVREDLyEAADKWVAAVGKDRPFMGGQ |
| Q9HCG8 | Y45 | Sugiyama | CWC22 KIAA1604 NCM | RNssPEDRYEEQERsPRDRDyFDYsRsDYEHSRRGRsYDsS |
| Q9NP61 | Y408 | Sugiyama | ARFGAP3 ARFGAP1 | ETVLKTTGYSDRPTARRKPDyEPVENTDEAQKKFGNVKAIs |
| Q9NP74 | T255 | Sugiyama | PALMD C1orf11 PALML | APVEVEELLRQASERNsKsPtEyHEPVyANPFyRPttPQRE |
| Q9NP74 | Y257 | Sugiyama | PALMD C1orf11 PALML | VEVEELLRQASERNsKsPtEyHEPVyANPFyRPttPQREtV |
| Q9NP74 | Y262 | Sugiyama | PALMD C1orf11 PALML | LLRQASERNsKsPtEyHEPVyANPFyRPttPQREtVtPGPN |
| Q9NPQ8 | Y446 | Sugiyama | RIC8A | MAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVEEKPPN |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NT99 | S702 | Sugiyama | LRRC4B LRIG4 | GCGGKGPPGLNSIHEPLLFKsGsKENVQETQI_________ |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NVS9 | Y195 | Sugiyama | PNPO | SSVIPDREYLRKKNEELEQLyQDQEVPKPKSWGGYVLYPQV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NYF8 | Y383 | Sugiyama | BCLAF1 BTF KIAA0164 | EKGSEKGRAEGEWEDQEALDyFsDKEsGKQKFNDsEGDDtE |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9P0J1 | Y381 | Sugiyama | PDP1 PDP PPM2C | SIDLQKRVIESGPDQLNDNEytKFIPPNYHTPPYLTAEPEV |
| Q9P0P0 | Y152 | Sugiyama | RNF181 HSPC238 | RDKARKQQQQHRLENLHGAMyt___________________ |
| Q9UBQ7 | Y255 | Sugiyama | GRHPR GLXR MSTP035 | KETAVFINISRGDVVNQDDLyQALAsGKIAAAGLDVtsPEP |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UHR5 | Y46 | Sugiyama | SAP30BP HCNGP HTRG HTRP | AGIEAVGSAAEEKGGLVsDAyGEDDFsRLGGDEDGYEEEED |
| Q9UHX1 | Y274 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | SCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNLFDLGG |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UIQ6 | Y70 | Sugiyama | LNPEP OTASE | GsRLLVRGLGEHEMEEDEEDyEssAKLLGMsFMNRssGLRN |
| Q9UJU6 | Y334 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DBNL CMAP SH3P7 PP5423 | AEEPAPSTPPCLVQAEEEAVyEEPPEQETFyEQPPLVQQQG |
| Q9UJU6 | Y344 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DBNL CMAP SH3P7 PP5423 | CLVQAEEEAVyEEPPEQETFyEQPPLVQQQGAGSEHIDHHI |
| Q9UKV8 | Y529 | PSP | AGO2 EIF2C2 | KNTYAGLQLVVVILPGKTPVyAEVKRVGDTVLGMATQCVQM |
| Q9UMS0 | Y194 | Sugiyama | NFU1 HIRIP5 CGI-33 | KELLDTRIRPTVQEDGGDVIyKGFEDGIVQLKLQGSCTSCP |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNP9 | Y300 | Sugiyama | PPIE CYP33 | AQGSKDGKPKQKVIIADCGEyV___________________ |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UQ80 | Y98 | Sugiyama | PA2G4 EBP1 | TSISVNNCVCHFsPLKSDQDyILKEGDLVKIDLGVHVDGFI |
| Q9UQC2 | Y614 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GAB2 KIAA0571 | SPVPSGTNSPAPKKSTGSVDyLALDFQPssPsPHRKPSTss |
| Q9UQQ2 | Y273 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | SH2B3 LNK | ACSSIQEVRWCTRLEMPDNLyTFVLKVKDRTDIIFEVGDEQ |
| Q9Y262 | Y409 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | QLREKYGDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYD |
| Q9Y262 | Y415 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | GDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPNY |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3S2 | Y315 | Sugiyama | ZNF330 NOA36 | ssDLFTNLNLGRTYAsGYAHyEEQEN_______________ |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y450 | Y56 | Sugiyama | HBS1L HBS1 KIAA1038 | TAAQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGF |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y490 | Y127 | Sugiyama | TLN1 KIAA1027 TLN | TVTDMLMTICARIGITNHDEysLVRELMEEKKEEItGtLRK |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y5S9 | Y96 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | FVTGVHEEATEEDIHDKFAEyGEIKNIHLNLDRRTGYLKGy |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | S245 | Sugiyama | CLIC4 | ysRDEFtNtCPsDKEVEIAysDVAKRLTK____________ |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.236683e-08 | 7.908 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.841446e-08 | 7.233 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.794767e-07 | 6.108 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.086201e-07 | 6.216 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.187868e-06 | 5.496 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.591458e-05 | 4.445 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.948550e-05 | 4.158 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.977509e-05 | 4.098 | 1 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.027140e-04 | 3.988 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.038253e-04 | 3.984 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.068761e-04 | 3.684 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.301162e-04 | 3.481 | 1 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.122133e-04 | 3.385 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 5.951689e-04 | 3.225 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.651325e-04 | 3.177 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.651325e-04 | 3.177 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.691626e-04 | 3.245 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 9.246314e-04 | 3.034 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.246314e-04 | 3.034 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.097763e-04 | 3.092 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.891580e-04 | 3.051 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.012996e-03 | 2.994 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.139070e-03 | 2.943 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.159091e-03 | 2.936 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.398394e-03 | 2.854 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.458350e-03 | 2.836 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.857577e-03 | 2.731 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.941484e-03 | 2.712 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 2.326719e-03 | 2.633 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.350562e-03 | 2.629 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.555129e-03 | 2.593 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.927954e-03 | 2.533 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.594149e-03 | 2.444 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.594149e-03 | 2.444 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.324143e-03 | 2.364 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.324143e-03 | 2.364 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.324143e-03 | 2.364 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.324143e-03 | 2.364 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.324143e-03 | 2.364 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.072254e-03 | 2.390 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.879500e-03 | 2.411 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.338519e-03 | 2.476 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.908003e-03 | 2.309 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.611359e-03 | 2.336 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.116788e-03 | 2.291 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.820251e-03 | 2.317 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.970953e-03 | 2.224 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.048228e-03 | 2.152 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.208088e-03 | 2.207 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.620194e-03 | 2.179 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.128620e-03 | 2.213 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.885520e-03 | 2.162 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.970908e-03 | 2.157 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.994858e-03 | 2.155 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.620194e-03 | 2.179 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.995754e-03 | 2.155 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.492333e-03 | 2.125 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 7.859386e-03 | 2.105 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.429308e-03 | 2.074 | 1 | 1 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.891463e-03 | 2.051 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.429308e-03 | 2.074 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.922430e-03 | 2.050 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.432134e-03 | 2.025 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.432134e-03 | 2.025 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.432134e-03 | 2.025 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.958528e-03 | 2.002 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.050172e-02 | 1.979 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.106179e-02 | 1.956 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.106179e-02 | 1.956 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.223296e-02 | 1.912 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.223296e-02 | 1.912 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.223296e-02 | 1.912 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.223296e-02 | 1.912 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.347269e-02 | 1.871 | 1 | 1 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.358060e-02 | 1.867 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.358060e-02 | 1.867 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.411842e-02 | 1.850 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.624717e-02 | 1.789 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.488790e-02 | 1.827 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.590181e-02 | 1.799 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.599484e-02 | 1.796 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.624717e-02 | 1.789 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.624717e-02 | 1.789 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.645980e-02 | 1.784 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.703897e-02 | 1.769 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.736089e-02 | 1.760 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.765742e-02 | 1.753 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.765742e-02 | 1.753 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.765742e-02 | 1.753 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.991208e-02 | 1.701 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.118883e-02 | 1.674 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.118883e-02 | 1.674 | 1 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.218434e-02 | 1.654 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.218434e-02 | 1.654 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.378885e-02 | 1.624 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.590446e-02 | 1.587 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.592877e-02 | 1.586 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.592877e-02 | 1.586 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.683096e-02 | 1.571 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.776721e-02 | 1.556 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.248652e-02 | 1.488 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.248652e-02 | 1.488 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.887604e-02 | 1.539 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.248652e-02 | 1.488 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.248652e-02 | 1.488 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.248652e-02 | 1.488 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.435483e-02 | 1.464 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 3.442247e-02 | 1.463 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 3.442247e-02 | 1.463 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 3.442247e-02 | 1.463 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 3.442247e-02 | 1.463 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.284263e-02 | 1.368 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.284263e-02 | 1.368 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.284263e-02 | 1.368 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.284263e-02 | 1.368 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.222872e-02 | 1.374 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.018972e-02 | 1.396 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.821332e-02 | 1.418 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.284263e-02 | 1.368 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.821332e-02 | 1.418 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.911049e-02 | 1.408 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.281736e-02 | 1.368 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.821332e-02 | 1.418 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.154713e-02 | 1.381 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.595661e-02 | 1.444 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.118988e-02 | 1.291 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.070432e-02 | 1.295 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.772909e-02 | 1.321 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.899858e-02 | 1.310 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.515200e-02 | 1.258 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.118988e-02 | 1.291 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.070432e-02 | 1.295 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.070432e-02 | 1.295 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.639451e-02 | 1.334 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.799731e-02 | 1.319 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.291131e-02 | 1.276 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.118988e-02 | 1.291 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.118988e-02 | 1.291 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.070432e-02 | 1.295 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.639451e-02 | 1.334 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.651544e-02 | 1.332 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.639451e-02 | 1.334 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.853180e-02 | 1.314 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.070432e-02 | 1.295 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.841185e-02 | 1.233 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.914994e-02 | 1.228 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.946485e-02 | 1.226 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.946485e-02 | 1.226 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.946485e-02 | 1.226 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.946485e-02 | 1.226 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.115428e-02 | 1.214 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.115428e-02 | 1.214 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.206889e-02 | 1.207 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.206889e-02 | 1.207 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.321573e-02 | 1.199 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.766815e-02 | 1.170 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.766815e-02 | 1.170 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.580041e-02 | 1.120 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.580041e-02 | 1.120 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.580041e-02 | 1.120 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.386223e-02 | 1.076 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 8.386223e-02 | 1.076 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.386223e-02 | 1.076 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 9.185423e-02 | 1.037 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 9.185423e-02 | 1.037 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.185423e-02 | 1.037 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.977699e-02 | 1.001 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.154172e-01 | 0.938 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.231358e-01 | 0.910 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.231358e-01 | 0.910 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.307876e-01 | 0.883 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.307876e-01 | 0.883 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.383731e-01 | 0.859 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.383731e-01 | 0.859 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.458928e-01 | 0.836 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.607373e-01 | 0.794 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.607373e-01 | 0.794 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.680632e-01 | 0.775 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 1.753256e-01 | 0.756 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 1.896621e-01 | 0.722 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.896621e-01 | 0.722 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.171919e-02 | 1.144 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 1.967373e-01 | 0.706 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.037511e-01 | 0.691 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.107041e-01 | 0.676 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.107041e-01 | 0.676 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.175968e-01 | 0.662 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.244298e-01 | 0.649 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.312035e-01 | 0.636 | 1 | 1 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.379185e-01 | 0.624 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.474201e-01 | 0.607 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.386223e-02 | 1.076 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 2.409673e-01 | 0.618 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.076311e-01 | 0.968 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.076311e-01 | 0.968 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.154172e-01 | 0.938 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.825250e-01 | 0.739 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 9.185423e-02 | 1.037 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.383731e-01 | 0.859 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.175968e-01 | 0.662 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.967373e-01 | 0.706 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.440779e-02 | 1.074 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.248774e-01 | 0.648 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.557149e-01 | 0.808 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.580041e-02 | 1.120 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.307876e-01 | 0.883 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.232343e-02 | 1.035 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.307876e-01 | 0.883 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.458928e-01 | 0.836 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.925356e-02 | 1.101 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.671519e-02 | 1.115 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.386223e-02 | 1.076 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.076311e-01 | 0.968 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.533473e-01 | 0.814 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.607373e-01 | 0.794 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.825250e-01 | 0.739 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.244298e-01 | 0.649 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.577159e-01 | 0.589 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.917885e-02 | 1.050 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.379185e-01 | 0.624 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.107041e-01 | 0.676 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.753256e-01 | 0.756 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 9.977699e-02 | 1.001 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.977699e-02 | 1.001 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.458928e-01 | 0.836 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.383731e-01 | 0.859 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.175968e-01 | 0.662 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.966114e-02 | 1.047 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.966114e-02 | 1.047 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.577159e-01 | 0.589 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.312575e-01 | 0.882 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.379185e-01 | 0.624 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.766815e-02 | 1.170 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.386223e-02 | 1.076 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.154172e-01 | 0.938 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.443705e-02 | 1.191 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.037511e-01 | 0.691 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.232869e-01 | 0.909 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 9.185423e-02 | 1.037 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.037511e-01 | 0.691 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.926289e-02 | 1.159 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.092408e-02 | 1.092 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.420351e-02 | 1.130 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 9.977699e-02 | 1.001 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.511742e-01 | 0.600 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.925356e-02 | 1.101 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.148676e-02 | 1.146 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.533473e-01 | 0.814 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.312035e-01 | 0.636 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.288122e-01 | 0.890 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.120684e-01 | 0.674 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.076311e-01 | 0.968 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.766815e-02 | 1.170 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.231358e-01 | 0.910 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.307876e-01 | 0.883 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.607373e-01 | 0.794 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.087583e-01 | 0.964 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.577159e-01 | 0.589 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.952984e-02 | 1.002 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.048794e-01 | 0.979 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.977699e-02 | 1.001 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.533473e-01 | 0.814 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.254195e-01 | 0.902 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.825250e-01 | 0.739 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.766815e-02 | 1.170 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.766815e-02 | 1.170 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.154172e-01 | 0.938 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.458928e-01 | 0.836 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.825250e-01 | 0.739 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.107041e-01 | 0.676 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.511742e-01 | 0.600 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.079636e-02 | 1.042 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.244298e-01 | 0.649 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.575579e-01 | 0.589 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.607373e-01 | 0.794 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.825250e-01 | 0.739 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.232343e-02 | 1.035 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.922417e-02 | 1.050 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.922417e-02 | 1.050 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.175968e-01 | 0.662 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.571103e-01 | 0.590 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.667351e-02 | 1.062 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.076311e-01 | 0.968 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.458928e-01 | 0.836 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.896621e-01 | 0.722 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.107041e-01 | 0.676 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.511742e-01 | 0.600 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 1.967373e-01 | 0.706 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.409673e-01 | 0.618 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.894154e-01 | 0.723 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.458928e-01 | 0.836 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.445752e-01 | 0.612 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.121847e-01 | 0.950 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.519508e-01 | 0.599 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.037511e-01 | 0.691 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.379185e-01 | 0.624 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 1.154172e-01 | 0.938 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.307876e-01 | 0.883 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.115690e-01 | 0.952 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.371874e-01 | 0.863 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.571103e-01 | 0.590 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.977699e-02 | 1.001 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.307876e-01 | 0.883 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.533473e-01 | 0.814 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.037511e-01 | 0.691 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.379185e-01 | 0.624 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.379185e-01 | 0.624 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.373082e-01 | 0.625 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.037511e-01 | 0.691 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.445752e-01 | 0.612 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.825250e-01 | 0.739 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.244298e-01 | 0.649 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.379185e-01 | 0.624 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.288122e-01 | 0.890 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.288122e-01 | 0.890 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.538791e-01 | 0.595 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.607373e-01 | 0.794 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.607373e-01 | 0.794 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.583545e-02 | 1.066 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.258958e-01 | 0.900 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.649085e-01 | 0.783 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.445752e-01 | 0.612 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 1.172466e-01 | 0.931 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.244298e-01 | 0.649 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 1.406313e-01 | 0.852 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.244298e-01 | 0.649 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.383731e-01 | 0.859 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.175968e-01 | 0.662 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.810454e-01 | 0.742 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.154172e-01 | 0.938 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.099352e-01 | 0.959 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.771623e-02 | 1.010 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.312035e-01 | 0.636 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.346920e-01 | 0.871 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.184645e-01 | 0.661 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.416003e-01 | 0.617 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.419437e-01 | 0.616 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.679944e-01 | 0.775 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.056917e-01 | 0.687 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.603422e-01 | 0.584 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.642009e-01 | 0.578 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.642009e-01 | 0.578 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.642009e-01 | 0.578 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.642009e-01 | 0.578 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.668074e-01 | 0.574 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.676856e-01 | 0.572 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.706296e-01 | 0.568 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.706296e-01 | 0.568 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.706296e-01 | 0.568 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.724033e-01 | 0.565 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.770026e-01 | 0.558 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.770026e-01 | 0.558 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 2.770026e-01 | 0.558 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.770026e-01 | 0.558 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.829662e-01 | 0.548 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.833203e-01 | 0.548 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.843995e-01 | 0.546 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.895831e-01 | 0.538 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.895831e-01 | 0.538 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.895831e-01 | 0.538 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.895831e-01 | 0.538 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.957917e-01 | 0.529 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 2.957917e-01 | 0.529 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.008739e-01 | 0.522 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.019463e-01 | 0.520 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.019463e-01 | 0.520 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.019463e-01 | 0.520 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.019463e-01 | 0.520 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.019463e-01 | 0.520 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.019463e-01 | 0.520 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.020549e-01 | 0.520 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.055335e-01 | 0.515 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.080475e-01 | 0.511 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.080475e-01 | 0.511 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.080475e-01 | 0.511 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.080475e-01 | 0.511 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.080475e-01 | 0.511 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.080475e-01 | 0.511 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.140958e-01 | 0.503 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.140958e-01 | 0.503 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.140958e-01 | 0.503 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.140958e-01 | 0.503 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.140958e-01 | 0.503 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.140958e-01 | 0.503 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.140958e-01 | 0.503 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.140958e-01 | 0.503 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.140958e-01 | 0.503 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.200916e-01 | 0.495 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.200916e-01 | 0.495 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.200916e-01 | 0.495 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.200916e-01 | 0.495 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.200916e-01 | 0.495 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.247763e-01 | 0.488 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.247763e-01 | 0.488 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.260353e-01 | 0.487 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.319112e-01 | 0.479 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.319274e-01 | 0.479 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.319274e-01 | 0.479 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.319274e-01 | 0.479 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.319274e-01 | 0.479 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.319274e-01 | 0.479 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.319274e-01 | 0.479 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.324916e-01 | 0.478 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.343490e-01 | 0.476 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.343490e-01 | 0.476 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.377684e-01 | 0.471 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.377684e-01 | 0.471 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.377684e-01 | 0.471 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.377684e-01 | 0.471 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.407096e-01 | 0.468 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.435587e-01 | 0.464 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.435587e-01 | 0.464 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.435587e-01 | 0.464 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.435587e-01 | 0.464 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.435587e-01 | 0.464 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.492987e-01 | 0.457 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.492987e-01 | 0.457 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.492987e-01 | 0.457 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.492987e-01 | 0.457 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.606296e-01 | 0.443 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.606296e-01 | 0.443 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.606296e-01 | 0.443 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.662214e-01 | 0.436 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.662214e-01 | 0.436 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 3.662214e-01 | 0.436 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 3.662214e-01 | 0.436 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.693817e-01 | 0.433 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.717646e-01 | 0.430 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.717646e-01 | 0.430 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.717646e-01 | 0.430 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.717646e-01 | 0.430 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.717646e-01 | 0.430 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.717646e-01 | 0.430 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.722098e-01 | 0.429 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.772597e-01 | 0.423 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.772597e-01 | 0.423 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.772597e-01 | 0.423 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.803011e-01 | 0.420 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.827071e-01 | 0.417 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.827071e-01 | 0.417 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.827071e-01 | 0.417 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.877399e-01 | 0.411 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.908262e-01 | 0.408 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.934602e-01 | 0.405 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.969781e-01 | 0.401 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.987668e-01 | 0.399 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.993527e-01 | 0.399 | 1 | 0 |
| Innate Immune System | R-HSA-168249 | 4.025566e-01 | 0.395 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.040274e-01 | 0.394 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.040274e-01 | 0.394 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.040274e-01 | 0.394 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.040274e-01 | 0.394 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.092422e-01 | 0.388 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.092422e-01 | 0.388 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.092422e-01 | 0.388 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.092422e-01 | 0.388 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.092422e-01 | 0.388 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.122323e-01 | 0.385 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.144117e-01 | 0.383 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.144117e-01 | 0.383 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.144117e-01 | 0.383 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.144117e-01 | 0.383 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.152607e-01 | 0.382 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.195363e-01 | 0.377 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.195363e-01 | 0.377 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.246164e-01 | 0.372 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.246164e-01 | 0.372 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.246164e-01 | 0.372 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.246164e-01 | 0.372 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.272965e-01 | 0.369 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.296523e-01 | 0.367 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.296523e-01 | 0.367 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.296523e-01 | 0.367 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.324030e-01 | 0.364 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.332663e-01 | 0.363 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.332663e-01 | 0.363 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.332782e-01 | 0.363 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.346444e-01 | 0.362 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.346444e-01 | 0.362 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.392031e-01 | 0.357 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.395932e-01 | 0.357 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.395932e-01 | 0.357 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.421589e-01 | 0.354 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.444989e-01 | 0.352 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.444989e-01 | 0.352 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.493620e-01 | 0.347 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.493620e-01 | 0.347 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.493620e-01 | 0.347 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.493620e-01 | 0.347 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.493620e-01 | 0.347 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.541829e-01 | 0.343 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.541829e-01 | 0.343 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.541829e-01 | 0.343 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.568092e-01 | 0.340 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.589618e-01 | 0.338 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.589618e-01 | 0.338 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.589618e-01 | 0.338 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.589618e-01 | 0.338 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.589618e-01 | 0.338 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.626078e-01 | 0.335 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.636991e-01 | 0.334 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.683953e-01 | 0.329 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.730507e-01 | 0.325 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.776655e-01 | 0.321 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.861667e-01 | 0.313 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.867752e-01 | 0.313 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 4.867752e-01 | 0.313 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.957272e-01 | 0.305 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.957272e-01 | 0.305 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.957272e-01 | 0.305 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.957272e-01 | 0.305 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.957272e-01 | 0.305 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.966276e-01 | 0.304 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 4.993052e-01 | 0.302 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.994011e-01 | 0.302 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.001448e-01 | 0.301 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.001448e-01 | 0.301 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.001448e-01 | 0.301 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.001448e-01 | 0.301 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.001448e-01 | 0.301 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.045240e-01 | 0.297 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.045240e-01 | 0.297 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.045240e-01 | 0.297 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.088651e-01 | 0.293 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.131685e-01 | 0.290 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.131685e-01 | 0.290 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.174344e-01 | 0.286 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.216632e-01 | 0.283 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.258552e-01 | 0.279 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.300107e-01 | 0.276 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.300107e-01 | 0.276 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.300107e-01 | 0.276 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.342212e-01 | 0.272 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.382136e-01 | 0.269 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.382136e-01 | 0.269 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.391268e-01 | 0.268 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.422615e-01 | 0.266 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.502140e-01 | 0.259 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.502521e-01 | 0.259 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.502521e-01 | 0.259 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.527872e-01 | 0.257 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.534319e-01 | 0.257 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.541952e-01 | 0.256 | 0 | 0 |
| Translation | R-HSA-72766 | 5.574168e-01 | 0.254 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.581041e-01 | 0.253 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.581041e-01 | 0.253 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.615094e-01 | 0.251 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.619789e-01 | 0.250 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.658200e-01 | 0.247 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.658200e-01 | 0.247 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.730003e-01 | 0.242 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.734020e-01 | 0.242 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.736040e-01 | 0.241 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 5.808527e-01 | 0.236 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.808527e-01 | 0.236 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 5.808527e-01 | 0.236 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.845294e-01 | 0.233 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.873063e-01 | 0.231 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 5.901413e-01 | 0.229 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.917870e-01 | 0.228 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.953684e-01 | 0.225 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.953684e-01 | 0.225 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.989187e-01 | 0.223 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.052185e-01 | 0.218 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.059267e-01 | 0.218 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.059267e-01 | 0.218 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.067706e-01 | 0.217 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.093850e-01 | 0.215 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.093850e-01 | 0.215 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.093850e-01 | 0.215 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.128131e-01 | 0.213 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.137407e-01 | 0.212 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.160432e-01 | 0.210 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.162114e-01 | 0.210 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.162114e-01 | 0.210 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.162114e-01 | 0.210 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.185521e-01 | 0.209 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.229193e-01 | 0.206 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.231326e-01 | 0.205 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.295108e-01 | 0.201 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.295108e-01 | 0.201 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 6.391841e-01 | 0.194 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.391841e-01 | 0.194 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.406836e-01 | 0.193 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.423525e-01 | 0.192 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.486066e-01 | 0.188 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.516928e-01 | 0.186 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.516928e-01 | 0.186 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.516928e-01 | 0.186 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.516928e-01 | 0.186 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.547521e-01 | 0.184 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.547521e-01 | 0.184 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 6.559674e-01 | 0.183 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.577848e-01 | 0.182 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.577848e-01 | 0.182 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.637709e-01 | 0.178 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.661392e-01 | 0.176 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.667248e-01 | 0.176 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.667248e-01 | 0.176 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.754330e-01 | 0.170 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.754330e-01 | 0.170 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 6.782852e-01 | 0.169 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.811125e-01 | 0.167 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.811125e-01 | 0.167 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.811125e-01 | 0.167 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.842703e-01 | 0.165 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.879702e-01 | 0.162 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.895824e-01 | 0.161 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.921772e-01 | 0.160 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.948832e-01 | 0.158 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 6.948832e-01 | 0.158 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.978135e-01 | 0.156 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.002247e-01 | 0.155 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.015943e-01 | 0.154 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.028605e-01 | 0.153 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.080633e-01 | 0.150 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.131757e-01 | 0.147 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.131757e-01 | 0.147 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.279854e-01 | 0.138 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.303788e-01 | 0.136 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.381766e-01 | 0.132 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.397450e-01 | 0.131 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 7.420356e-01 | 0.130 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.439830e-01 | 0.128 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.443062e-01 | 0.128 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.443062e-01 | 0.128 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.487880e-01 | 0.126 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.487880e-01 | 0.126 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.487880e-01 | 0.126 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.509996e-01 | 0.124 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.553649e-01 | 0.122 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.638689e-01 | 0.117 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.647353e-01 | 0.116 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.654959e-01 | 0.116 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.659486e-01 | 0.116 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 7.659486e-01 | 0.116 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.680102e-01 | 0.115 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.760776e-01 | 0.110 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 7.760776e-01 | 0.110 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.780505e-01 | 0.109 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.800062e-01 | 0.108 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.800062e-01 | 0.108 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.838663e-01 | 0.106 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.895308e-01 | 0.103 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.913860e-01 | 0.102 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.986459e-01 | 0.098 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.014156e-01 | 0.096 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.045544e-01 | 0.094 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.110234e-01 | 0.091 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.173425e-01 | 0.088 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.189542e-01 | 0.087 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.268032e-01 | 0.083 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.313494e-01 | 0.080 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.328383e-01 | 0.079 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.360863e-01 | 0.078 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.400894e-01 | 0.076 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 8.562427e-01 | 0.067 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.575133e-01 | 0.067 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.587728e-01 | 0.066 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.707748e-01 | 0.060 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.707748e-01 | 0.060 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.713132e-01 | 0.060 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 8.774840e-01 | 0.057 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.803430e-01 | 0.055 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.807077e-01 | 0.055 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.869046e-01 | 0.052 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 8.888983e-01 | 0.051 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 8.898821e-01 | 0.051 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.937313e-01 | 0.049 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.965303e-01 | 0.047 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.053421e-01 | 0.043 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.300895e-01 | 0.031 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.300895e-01 | 0.031 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.399340e-01 | 0.027 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.519638e-01 | 0.021 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.667298e-01 | 0.015 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.775918e-01 | 0.010 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.804215e-01 | 0.009 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.812835e-01 | 0.008 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.853400e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.854587e-01 | 0.006 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.933945e-01 | 0.003 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.956823e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.966329e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.966847e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.998857e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999896e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.440892e-16 | 15.353 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.551115e-16 | 15.256 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.661338e-16 | 15.176 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.105427e-15 | 14.148 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.620926e-14 | 13.790 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.420286e-14 | 13.616 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.727952e-14 | 13.172 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.727952e-14 | 13.172 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.370282e-14 | 13.028 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.014744e-13 | 12.994 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.150191e-13 | 12.939 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.262324e-13 | 12.899 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.358913e-13 | 12.867 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.040901e-13 | 12.517 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.622658e-13 | 12.441 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.012346e-13 | 12.397 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.304646e-13 | 12.275 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.836753e-13 | 12.165 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.836753e-13 | 12.165 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.134870e-12 | 11.945 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.436629e-12 | 11.843 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.449063e-12 | 11.839 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.449063e-12 | 11.839 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.784350e-12 | 11.749 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.839640e-12 | 11.735 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.316258e-12 | 11.635 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.704614e-12 | 11.568 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.917777e-12 | 11.535 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.917777e-12 | 11.535 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.123279e-12 | 11.505 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.646972e-12 | 11.438 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.617284e-12 | 11.250 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.617284e-12 | 11.250 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.925016e-12 | 11.160 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.150569e-12 | 11.039 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.002942e-11 | 10.999 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.039369e-11 | 10.983 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.039369e-11 | 10.983 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.254197e-11 | 10.902 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.856448e-11 | 10.731 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.646472e-11 | 10.577 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.212652e-11 | 10.493 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.117995e-11 | 10.385 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.557277e-11 | 10.341 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.403544e-11 | 10.267 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.240608e-11 | 10.084 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.038782e-10 | 9.983 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.074405e-10 | 9.969 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.215226e-10 | 9.915 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.391738e-10 | 9.856 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.791653e-10 | 9.747 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.817622e-10 | 9.740 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.917747e-10 | 9.717 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.917747e-10 | 9.717 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.415342e-10 | 9.467 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.925115e-10 | 9.406 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.146007e-10 | 9.382 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.889775e-10 | 9.230 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.677106e-10 | 9.175 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.093788e-10 | 9.092 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.695075e-10 | 9.061 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.807336e-10 | 9.055 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.177404e-09 | 8.929 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.323901e-09 | 8.878 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.323901e-09 | 8.878 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.323901e-09 | 8.878 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.678196e-09 | 8.775 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.259122e-09 | 8.646 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.288634e-09 | 8.640 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.288634e-09 | 8.640 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.212428e-09 | 8.493 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.587349e-09 | 8.445 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.794438e-09 | 8.319 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.779721e-09 | 8.169 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.507905e-09 | 8.124 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.979601e-09 | 8.047 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.462617e-09 | 8.024 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.149240e-08 | 7.940 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.526775e-08 | 7.816 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.447900e-08 | 7.839 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.593115e-08 | 7.798 | 1 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.635061e-08 | 7.786 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.856056e-08 | 7.731 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.274886e-08 | 7.643 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.613966e-08 | 7.583 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.351718e-08 | 7.475 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.351718e-08 | 7.475 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.602119e-08 | 7.337 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.756883e-08 | 7.240 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.061463e-08 | 7.151 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.642857e-08 | 7.117 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.007057e-07 | 6.997 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.097774e-07 | 6.959 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.172587e-07 | 6.931 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.211338e-07 | 6.917 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.365641e-07 | 6.865 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.511857e-07 | 6.820 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.161359e-07 | 6.665 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.161359e-07 | 6.665 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.161359e-07 | 6.665 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.025541e-07 | 6.693 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.101789e-07 | 6.677 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.984948e-07 | 6.702 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.258194e-07 | 6.487 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.756655e-07 | 6.425 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.480828e-07 | 6.349 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.309599e-07 | 6.200 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.977272e-07 | 6.156 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.210345e-07 | 6.086 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.799675e-07 | 6.056 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.016458e-07 | 6.045 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.124645e-06 | 5.949 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.255815e-06 | 5.901 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.303622e-06 | 5.885 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.438468e-06 | 5.842 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.739866e-06 | 5.759 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.583556e-06 | 5.800 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.497890e-06 | 5.825 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.602196e-06 | 5.795 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.571050e-06 | 5.804 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.812232e-06 | 5.742 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.816530e-06 | 5.741 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.866952e-06 | 5.729 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.036477e-06 | 5.691 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.322631e-06 | 5.634 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.388820e-06 | 5.622 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.447263e-06 | 5.611 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.475738e-06 | 5.349 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.585591e-06 | 5.339 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.013306e-06 | 5.096 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.732143e-06 | 5.059 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.030007e-05 | 4.987 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.039353e-05 | 4.983 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.043156e-05 | 4.982 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.065482e-05 | 4.972 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.081121e-05 | 4.966 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.167836e-05 | 4.933 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.338304e-05 | 4.873 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.008021e-05 | 4.697 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.008021e-05 | 4.697 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.008021e-05 | 4.697 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.008021e-05 | 4.697 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.725111e-05 | 4.763 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.187772e-05 | 4.660 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.889303e-05 | 4.539 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.508010e-05 | 4.346 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.633388e-05 | 4.334 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.811868e-05 | 4.318 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.250593e-05 | 4.204 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.290270e-05 | 4.137 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.336065e-05 | 4.135 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.733157e-05 | 4.112 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.135068e-05 | 4.090 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.026683e-05 | 4.044 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.026683e-05 | 4.044 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.053255e-05 | 4.043 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.467731e-05 | 4.024 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.784389e-05 | 4.009 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.015091e-04 | 3.993 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.129067e-04 | 3.947 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.223484e-04 | 3.912 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.229142e-04 | 3.910 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.489856e-04 | 3.827 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.982974e-04 | 3.703 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.834046e-04 | 3.737 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.716270e-04 | 3.765 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.589382e-04 | 3.799 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.593940e-04 | 3.798 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.772617e-04 | 3.751 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.088715e-04 | 3.680 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.135703e-04 | 3.670 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.472346e-04 | 3.607 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.653054e-04 | 3.576 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.067551e-04 | 3.513 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.264935e-04 | 3.486 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.481144e-04 | 3.458 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.599656e-04 | 3.444 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.839389e-04 | 3.315 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.279368e-04 | 3.277 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.157359e-04 | 3.211 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.183724e-04 | 3.209 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.205851e-04 | 3.207 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.090772e-04 | 3.149 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.496571e-04 | 3.125 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.169430e-04 | 3.088 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.203529e-04 | 3.086 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.355904e-04 | 3.078 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.755901e-04 | 3.011 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.059257e-03 | 2.975 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.078206e-03 | 2.967 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.129610e-03 | 2.947 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.176749e-03 | 2.929 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.298166e-03 | 2.887 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.411656e-03 | 2.850 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.430102e-03 | 2.845 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.467699e-03 | 2.833 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.481752e-03 | 2.829 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.701661e-03 | 2.769 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.711402e-03 | 2.767 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.757276e-03 | 2.755 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.859495e-03 | 2.731 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.960341e-03 | 2.708 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.223196e-03 | 2.653 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.016360e-03 | 2.521 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.792699e-03 | 2.421 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.988906e-03 | 2.524 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.225434e-03 | 2.491 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.053721e-03 | 2.515 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.109461e-03 | 2.507 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.171866e-03 | 2.499 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.883065e-03 | 2.411 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.883065e-03 | 2.411 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.079806e-03 | 2.389 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.651852e-03 | 2.332 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.788926e-03 | 2.320 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.231112e-03 | 2.281 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.352803e-03 | 2.271 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.592113e-03 | 2.252 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.739386e-03 | 2.241 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.483045e-03 | 2.188 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.611805e-03 | 2.180 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.611805e-03 | 2.180 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.611805e-03 | 2.180 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.798632e-03 | 2.168 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.211386e-03 | 2.142 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.296677e-03 | 2.137 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.709273e-03 | 2.113 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.709273e-03 | 2.113 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.784005e-03 | 2.109 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.882890e-03 | 2.051 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.882890e-03 | 2.051 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.501540e-03 | 2.022 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.501540e-03 | 2.022 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 9.948629e-03 | 2.002 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 9.948629e-03 | 2.002 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 9.948629e-03 | 2.002 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 9.948629e-03 | 2.002 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 9.948629e-03 | 2.002 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 9.948629e-03 | 2.002 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 9.948629e-03 | 2.002 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 9.948629e-03 | 2.002 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 9.948629e-03 | 2.002 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 9.948629e-03 | 2.002 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 9.948629e-03 | 2.002 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 9.948629e-03 | 2.002 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 9.948629e-03 | 2.002 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 9.948629e-03 | 2.002 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 9.948629e-03 | 2.002 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 9.948629e-03 | 2.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.990682e-03 | 2.000 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.030271e-02 | 1.987 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.045242e-02 | 1.981 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.129959e-02 | 1.947 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.129959e-02 | 1.947 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.138338e-02 | 1.944 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.145218e-02 | 1.941 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.284471e-02 | 1.891 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.304896e-02 | 1.884 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.420392e-02 | 1.848 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.430711e-02 | 1.844 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.430711e-02 | 1.844 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.430711e-02 | 1.844 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.430711e-02 | 1.844 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.001284e-02 | 1.699 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.655647e-02 | 1.781 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.142563e-02 | 1.669 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.142563e-02 | 1.669 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.142563e-02 | 1.669 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.046045e-02 | 1.689 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.823883e-02 | 1.739 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.583788e-02 | 1.800 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.823883e-02 | 1.739 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.574954e-02 | 1.803 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.001284e-02 | 1.699 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.743552e-02 | 1.759 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.583788e-02 | 1.800 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.173163e-02 | 1.663 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.082560e-02 | 1.681 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.005237e-02 | 1.698 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.991625e-02 | 1.701 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.627954e-02 | 1.788 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.176532e-02 | 1.662 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.261517e-02 | 1.646 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.261517e-02 | 1.646 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.261517e-02 | 1.646 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.284614e-02 | 1.641 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.446589e-02 | 1.611 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.446589e-02 | 1.611 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.491713e-02 | 1.604 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.524659e-02 | 1.598 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.588628e-02 | 1.587 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.637638e-02 | 1.579 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.637638e-02 | 1.579 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.637638e-02 | 1.579 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.637638e-02 | 1.579 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.637638e-02 | 1.579 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.802778e-02 | 1.552 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.802778e-02 | 1.552 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.834528e-02 | 1.548 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.955175e-02 | 1.529 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.955175e-02 | 1.529 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.955175e-02 | 1.529 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.996923e-02 | 1.523 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.008540e-02 | 1.522 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.037126e-02 | 1.518 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.037126e-02 | 1.518 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.141148e-02 | 1.503 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.231601e-02 | 1.491 | 1 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.231601e-02 | 1.491 | 1 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.245301e-02 | 1.489 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.271792e-02 | 1.485 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.458922e-02 | 1.461 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.458922e-02 | 1.461 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.490518e-02 | 1.457 | 1 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.901997e-02 | 1.409 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.901997e-02 | 1.409 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.920817e-02 | 1.407 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.920817e-02 | 1.407 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.920817e-02 | 1.407 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.920817e-02 | 1.407 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.920817e-02 | 1.407 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.131201e-02 | 1.384 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.365354e-02 | 1.360 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.365354e-02 | 1.360 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.365354e-02 | 1.360 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.604335e-02 | 1.337 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.748259e-02 | 1.323 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.876910e-02 | 1.312 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.876910e-02 | 1.312 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.984403e-02 | 1.302 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.987202e-02 | 1.302 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.096314e-02 | 1.293 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.096314e-02 | 1.293 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.096314e-02 | 1.293 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.349081e-02 | 1.272 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.349081e-02 | 1.272 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 5.550329e-02 | 1.256 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.592969e-02 | 1.252 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.606215e-02 | 1.251 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.823547e-02 | 1.235 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.823547e-02 | 1.235 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.867607e-02 | 1.232 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.867607e-02 | 1.232 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.908413e-02 | 1.229 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.760821e-02 | 1.170 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.760821e-02 | 1.170 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.688824e-02 | 1.114 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.688824e-02 | 1.114 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 8.607648e-02 | 1.065 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.607648e-02 | 1.065 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 8.607648e-02 | 1.065 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.517383e-02 | 1.021 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.517383e-02 | 1.021 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.041812e-01 | 0.982 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.041812e-01 | 0.982 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.219294e-01 | 0.914 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.219294e-01 | 0.914 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.133147e-02 | 1.212 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.676245e-02 | 1.175 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.402729e-02 | 1.194 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.130994e-01 | 0.947 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.041812e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.219294e-01 | 0.914 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.219294e-01 | 0.914 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.242496e-02 | 1.140 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.099282e-02 | 1.092 | 1 | 1 |
| PTK6 Expression | R-HSA-8849473 | 9.517383e-02 | 1.021 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.041812e-01 | 0.982 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.130994e-01 | 0.947 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.688824e-02 | 1.114 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.916117e-02 | 1.004 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.769422e-02 | 1.010 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.688824e-02 | 1.114 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.130994e-01 | 0.947 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.519377e-02 | 1.124 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.339543e-02 | 1.079 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.402729e-02 | 1.194 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.130994e-01 | 0.947 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.099282e-02 | 1.092 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.219865e-01 | 0.914 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.519377e-02 | 1.124 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.041812e-01 | 0.982 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.130994e-01 | 0.947 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.219294e-01 | 0.914 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.043852e-01 | 0.981 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.605812e-02 | 1.017 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.760821e-02 | 1.170 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.607648e-02 | 1.065 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.219294e-01 | 0.914 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.786913e-02 | 1.109 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.688824e-02 | 1.114 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.688824e-02 | 1.114 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.688824e-02 | 1.114 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.607648e-02 | 1.065 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.517383e-02 | 1.021 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.130994e-01 | 0.947 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.296741e-02 | 1.032 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.519377e-02 | 1.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.916117e-02 | 1.004 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.009368e-01 | 0.996 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.938417e-02 | 1.049 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.060057e-02 | 1.043 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.234671e-02 | 1.141 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.029708e-01 | 0.987 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.086345e-01 | 0.964 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.112680e-01 | 0.954 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.041812e-01 | 0.982 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.210695e-02 | 1.036 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.953593e-02 | 1.158 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.969273e-02 | 1.099 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.086345e-01 | 0.964 | 1 | 1 |
| Post-translational protein modification | R-HSA-597592 | 1.150327e-01 | 0.939 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.402729e-02 | 1.194 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.510823e-02 | 1.022 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.915208e-02 | 1.050 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.298388e-02 | 1.032 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.298388e-02 | 1.032 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.605812e-02 | 1.017 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.216178e-01 | 0.915 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.022922e-01 | 0.990 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.807613e-02 | 1.107 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.282461e-01 | 0.892 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.285930e-01 | 0.891 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.306720e-01 | 0.884 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.306720e-01 | 0.884 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.306720e-01 | 0.884 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.306720e-01 | 0.884 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.349573e-01 | 0.870 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.349573e-01 | 0.870 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.349573e-01 | 0.870 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.393281e-01 | 0.856 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.393281e-01 | 0.856 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.393281e-01 | 0.856 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.393281e-01 | 0.856 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.417456e-01 | 0.848 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.444844e-01 | 0.840 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.468060e-01 | 0.833 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.478986e-01 | 0.830 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.478986e-01 | 0.830 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.478986e-01 | 0.830 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.478986e-01 | 0.830 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.478986e-01 | 0.830 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.478986e-01 | 0.830 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.478986e-01 | 0.830 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.478986e-01 | 0.830 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.520605e-01 | 0.818 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.555314e-01 | 0.808 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.563842e-01 | 0.806 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.563842e-01 | 0.806 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.563842e-01 | 0.806 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.563842e-01 | 0.806 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.625181e-01 | 0.789 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.647859e-01 | 0.783 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.647859e-01 | 0.783 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.658717e-01 | 0.780 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.682270e-01 | 0.774 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.731011e-01 | 0.762 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.731043e-01 | 0.762 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.731043e-01 | 0.762 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.731043e-01 | 0.762 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.731043e-01 | 0.762 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.731043e-01 | 0.762 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.731043e-01 | 0.762 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.766538e-01 | 0.753 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.775107e-01 | 0.751 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.813405e-01 | 0.742 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.813405e-01 | 0.742 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.813405e-01 | 0.742 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.813405e-01 | 0.742 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.813405e-01 | 0.742 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.813405e-01 | 0.742 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.813680e-01 | 0.741 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.837931e-01 | 0.736 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.854785e-01 | 0.732 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.873786e-01 | 0.727 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.873786e-01 | 0.727 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 1.873786e-01 | 0.727 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 1.873786e-01 | 0.727 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.874166e-01 | 0.727 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.894951e-01 | 0.722 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.894951e-01 | 0.722 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.894951e-01 | 0.722 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.909740e-01 | 0.719 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.945786e-01 | 0.711 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.975690e-01 | 0.704 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.975690e-01 | 0.704 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.975690e-01 | 0.704 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.975690e-01 | 0.704 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.975690e-01 | 0.704 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.018135e-01 | 0.695 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.055630e-01 | 0.687 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.055630e-01 | 0.687 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.055630e-01 | 0.687 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.055630e-01 | 0.687 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.055630e-01 | 0.687 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.055630e-01 | 0.687 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.055630e-01 | 0.687 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.127225e-01 | 0.672 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.134778e-01 | 0.671 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.134778e-01 | 0.671 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.134778e-01 | 0.671 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.134778e-01 | 0.671 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.134778e-01 | 0.671 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.163718e-01 | 0.665 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.186393e-01 | 0.660 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.190865e-01 | 0.659 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.200269e-01 | 0.658 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.200269e-01 | 0.658 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.200269e-01 | 0.658 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.213142e-01 | 0.655 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.213142e-01 | 0.655 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.264636e-01 | 0.645 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.290730e-01 | 0.640 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.290730e-01 | 0.640 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.290730e-01 | 0.640 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.290730e-01 | 0.640 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.367551e-01 | 0.626 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.367551e-01 | 0.626 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.367551e-01 | 0.626 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.383720e-01 | 0.623 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.386466e-01 | 0.622 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.420518e-01 | 0.616 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.420518e-01 | 0.616 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.422685e-01 | 0.616 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.443610e-01 | 0.612 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.443610e-01 | 0.612 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.457342e-01 | 0.610 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.457342e-01 | 0.610 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.494188e-01 | 0.603 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.494188e-01 | 0.603 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.518916e-01 | 0.599 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.518916e-01 | 0.599 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.518916e-01 | 0.599 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.518916e-01 | 0.599 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.518916e-01 | 0.599 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.518916e-01 | 0.599 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.529054e-01 | 0.597 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.531052e-01 | 0.597 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.593476e-01 | 0.586 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.593476e-01 | 0.586 | 1 | 1 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.593476e-01 | 0.586 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.593476e-01 | 0.586 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.593476e-01 | 0.586 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.593476e-01 | 0.586 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.593476e-01 | 0.586 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.593476e-01 | 0.586 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.593476e-01 | 0.586 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.667298e-01 | 0.574 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.667298e-01 | 0.574 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.667298e-01 | 0.574 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.667298e-01 | 0.574 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.667298e-01 | 0.574 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.678608e-01 | 0.572 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.740388e-01 | 0.562 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.740388e-01 | 0.562 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.743704e-01 | 0.562 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.812754e-01 | 0.551 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.812754e-01 | 0.551 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.812754e-01 | 0.551 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.812754e-01 | 0.551 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.812754e-01 | 0.551 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.884404e-01 | 0.540 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.884404e-01 | 0.540 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.884404e-01 | 0.540 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.884404e-01 | 0.540 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.884404e-01 | 0.540 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.899835e-01 | 0.538 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.936649e-01 | 0.532 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.955343e-01 | 0.529 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.955343e-01 | 0.529 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.955343e-01 | 0.529 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.955343e-01 | 0.529 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.960195e-01 | 0.529 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.014511e-01 | 0.521 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.014511e-01 | 0.521 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.025580e-01 | 0.519 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.025580e-01 | 0.519 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.025580e-01 | 0.519 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.025580e-01 | 0.519 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.046928e-01 | 0.516 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.068614e-01 | 0.513 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.068879e-01 | 0.513 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.095120e-01 | 0.509 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.095120e-01 | 0.509 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.095120e-01 | 0.509 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.095120e-01 | 0.509 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.095120e-01 | 0.509 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.120281e-01 | 0.506 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.120281e-01 | 0.506 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.163972e-01 | 0.500 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.193474e-01 | 0.496 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.232141e-01 | 0.491 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.232141e-01 | 0.491 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.232141e-01 | 0.491 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.232141e-01 | 0.491 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.232141e-01 | 0.491 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.232141e-01 | 0.491 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.232141e-01 | 0.491 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.232141e-01 | 0.491 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.299634e-01 | 0.482 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.299634e-01 | 0.482 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.299634e-01 | 0.482 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.299634e-01 | 0.482 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.302914e-01 | 0.481 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.366459e-01 | 0.473 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.366459e-01 | 0.473 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.366459e-01 | 0.473 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.375610e-01 | 0.472 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.375610e-01 | 0.472 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.432621e-01 | 0.464 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.432621e-01 | 0.464 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.432621e-01 | 0.464 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.447453e-01 | 0.463 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.498128e-01 | 0.456 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.498128e-01 | 0.456 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.498128e-01 | 0.456 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.520281e-01 | 0.453 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.562985e-01 | 0.448 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.562985e-01 | 0.448 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.627199e-01 | 0.440 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.627199e-01 | 0.440 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.627199e-01 | 0.440 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.690776e-01 | 0.433 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.690776e-01 | 0.433 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.690776e-01 | 0.433 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.690776e-01 | 0.433 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.690776e-01 | 0.433 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.690776e-01 | 0.433 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.690776e-01 | 0.433 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.699576e-01 | 0.432 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.699576e-01 | 0.432 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.735208e-01 | 0.428 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.735208e-01 | 0.428 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.753723e-01 | 0.426 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.753723e-01 | 0.426 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.753723e-01 | 0.426 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.753723e-01 | 0.426 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.753723e-01 | 0.426 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.753723e-01 | 0.426 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.753723e-01 | 0.426 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.753723e-01 | 0.426 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.753723e-01 | 0.426 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.753723e-01 | 0.426 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.753723e-01 | 0.426 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.753723e-01 | 0.426 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.816046e-01 | 0.418 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.816046e-01 | 0.418 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.816046e-01 | 0.418 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.816046e-01 | 0.418 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.816046e-01 | 0.418 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.816046e-01 | 0.418 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 3.829388e-01 | 0.417 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.877751e-01 | 0.411 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.877751e-01 | 0.411 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.877751e-01 | 0.411 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.938844e-01 | 0.405 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.938844e-01 | 0.405 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.938844e-01 | 0.405 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.982270e-01 | 0.400 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.999331e-01 | 0.398 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.017206e-01 | 0.396 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.059218e-01 | 0.392 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.086793e-01 | 0.389 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.097548e-01 | 0.387 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.118511e-01 | 0.385 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.177216e-01 | 0.379 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.177216e-01 | 0.379 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.177216e-01 | 0.379 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.177216e-01 | 0.379 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.177216e-01 | 0.379 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.177216e-01 | 0.379 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.177216e-01 | 0.379 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.177216e-01 | 0.379 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.235339e-01 | 0.373 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.235339e-01 | 0.373 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.259024e-01 | 0.371 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.292885e-01 | 0.367 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.292885e-01 | 0.367 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.292885e-01 | 0.367 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.327192e-01 | 0.364 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.349860e-01 | 0.362 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.349860e-01 | 0.362 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.406270e-01 | 0.356 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.406270e-01 | 0.356 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.462120e-01 | 0.350 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.462120e-01 | 0.350 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.492853e-01 | 0.347 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.517416e-01 | 0.345 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.517416e-01 | 0.345 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.517416e-01 | 0.345 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.544795e-01 | 0.342 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.572163e-01 | 0.340 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.572163e-01 | 0.340 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.572163e-01 | 0.340 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.572163e-01 | 0.340 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.572163e-01 | 0.340 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.572163e-01 | 0.340 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.626367e-01 | 0.335 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.628494e-01 | 0.335 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.680033e-01 | 0.330 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.694185e-01 | 0.328 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.733166e-01 | 0.325 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.733166e-01 | 0.325 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.733166e-01 | 0.325 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 4.750498e-01 | 0.323 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.759400e-01 | 0.322 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.785772e-01 | 0.320 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.837856e-01 | 0.315 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.889422e-01 | 0.311 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.889422e-01 | 0.311 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.889422e-01 | 0.311 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.920306e-01 | 0.308 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.940477e-01 | 0.306 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.940477e-01 | 0.306 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.983801e-01 | 0.302 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.991025e-01 | 0.302 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.991025e-01 | 0.302 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.015359e-01 | 0.300 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.041070e-01 | 0.297 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.041070e-01 | 0.297 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.041070e-01 | 0.297 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.041070e-01 | 0.297 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.090619e-01 | 0.293 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.090619e-01 | 0.293 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.090619e-01 | 0.293 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.109270e-01 | 0.292 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.139676e-01 | 0.289 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.139676e-01 | 0.289 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.139676e-01 | 0.289 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.139676e-01 | 0.289 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.171236e-01 | 0.286 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.188246e-01 | 0.285 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.232683e-01 | 0.281 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.283943e-01 | 0.277 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.323874e-01 | 0.274 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.331079e-01 | 0.273 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.331079e-01 | 0.273 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.423953e-01 | 0.266 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.469699e-01 | 0.262 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.514990e-01 | 0.258 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.514990e-01 | 0.258 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.532021e-01 | 0.257 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.559832e-01 | 0.255 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.559832e-01 | 0.255 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.559832e-01 | 0.255 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.604227e-01 | 0.251 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.691700e-01 | 0.245 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.734785e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.777442e-01 | 0.238 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.777442e-01 | 0.238 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.901098e-01 | 0.229 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.902886e-01 | 0.229 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.943872e-01 | 0.226 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.024626e-01 | 0.220 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.103782e-01 | 0.214 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.103782e-01 | 0.214 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.181371e-01 | 0.209 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.405045e-01 | 0.193 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.441036e-01 | 0.191 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.476670e-01 | 0.189 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.476670e-01 | 0.189 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.497871e-01 | 0.187 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.546877e-01 | 0.184 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.581457e-01 | 0.182 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.615693e-01 | 0.179 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.649589e-01 | 0.177 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.649589e-01 | 0.177 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.649589e-01 | 0.177 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.649589e-01 | 0.177 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.649589e-01 | 0.177 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.688217e-01 | 0.175 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.716371e-01 | 0.173 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.749264e-01 | 0.171 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.908882e-01 | 0.161 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.908882e-01 | 0.161 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.970527e-01 | 0.157 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.000889e-01 | 0.155 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.000889e-01 | 0.155 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.030949e-01 | 0.153 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.035847e-01 | 0.153 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.060709e-01 | 0.151 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.060709e-01 | 0.151 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.148224e-01 | 0.146 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.205123e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.233148e-01 | 0.141 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.315559e-01 | 0.136 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.315559e-01 | 0.136 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.369139e-01 | 0.133 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.369139e-01 | 0.133 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.369139e-01 | 0.133 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.421657e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.447524e-01 | 0.128 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.447524e-01 | 0.128 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.473133e-01 | 0.126 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.483294e-01 | 0.126 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.621511e-01 | 0.118 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.738521e-01 | 0.111 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.849809e-01 | 0.105 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.849809e-01 | 0.105 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.892785e-01 | 0.103 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.036586e-01 | 0.095 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.039019e-01 | 0.095 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.095190e-01 | 0.092 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.114335e-01 | 0.091 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.114335e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.114335e-01 | 0.091 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.249402e-01 | 0.084 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.312721e-01 | 0.080 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.505547e-01 | 0.070 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.505547e-01 | 0.070 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.520590e-01 | 0.070 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.621763e-01 | 0.064 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.696674e-01 | 0.061 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.728994e-01 | 0.059 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.754480e-01 | 0.058 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.767031e-01 | 0.057 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.780958e-01 | 0.056 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.791759e-01 | 0.056 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.987173e-01 | 0.046 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.031627e-01 | 0.044 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.090383e-01 | 0.041 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.210905e-01 | 0.036 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.233488e-01 | 0.035 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.242326e-01 | 0.034 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.377525e-01 | 0.028 | 0 | 0 |
| Translation | R-HSA-72766 | 9.413037e-01 | 0.026 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.420556e-01 | 0.026 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.430059e-01 | 0.025 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.505779e-01 | 0.022 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.525515e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.832738e-01 | 0.007 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.850588e-01 | 0.007 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.960458e-01 | 0.002 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.980055e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996238e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.997800e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
